Sarmiento, Rommel .
HRN: 27-35-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/19/2025
06/26/2025
IV
4.5g
Q6H
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes